Research ArticleBasic Science Investigation
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky and Ganesan Vaidyanathan
Journal of Nuclear Medicine November 2021, 62 (11) 1624-1630; DOI: https://doi.org/10.2967/jnumed.120.261446
Zhengyuan Zhou
Department of Radiology, Duke University Medical Center, Durham, North Carolina
Rebecca Meshaw
Department of Radiology, Duke University Medical Center, Durham, North Carolina
Michael R. Zalutsky
Department of Radiology, Duke University Medical Center, Durham, North Carolina
Ganesan Vaidyanathan
Department of Radiology, Duke University Medical Center, Durham, North Carolina
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 11
November 1, 2021
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky, Ganesan Vaidyanathan
Journal of Nuclear Medicine Nov 2021, 62 (11) 1624-1630; DOI: 10.2967/jnumed.120.261446
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment
Zhengyuan Zhou, Rebecca Meshaw, Michael R. Zalutsky, Ganesan Vaidyanathan
Journal of Nuclear Medicine Nov 2021, 62 (11) 1624-1630; DOI: 10.2967/jnumed.120.261446